Company name Secuped
Year of establishment 2025
Sector Life Sciences & Health
Website https://secuped.com/cms/
Status Active

Secuped

Secuped is a medtech company creating an at‑home device that automatically measures foot temperatures daily at risk points to detect early signs of ulcers in diabetic patients. Targeting the highest‑risk 6% of diabetics, its solution aims to prevent severe infections and amputations by enabling timely intervention.

This investment is managed by

Bart Hoenen, Investment Manger (LEH) at UNIIQ.

Connect on LinkedIn Mail Mail Contact via UNIIQ

For co-investors: download the full UNIIQ portfolio
and explore ventures ready for follow-on investment.

Download portfolio
© Copyright - UNIIQ